- BBS Pharmaceuticals Contact
- contact@bbspharmaceuticals.com
BBS Pharmaceuticals News
Export Control Legislation Amendment (Certification of Narcotic Exports) Bill passes in Australia… - BBS Pharmaceuticals, a licensed cultivator and manufacturer of medicinal cannabis products would like to congratulate Minister David Littleproud and the… […]
Adrian Pederick MP applauds BBS on their site progress… - It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour… […]
Regional Development Australia Murraylands & Riverland impressed with BBS’s progress - It has been a busy and incredibly productive start of the week here at BBS as we are entering the… […] Local MP, Adrian Pederick visits BBS’s facility… - It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour… […]
Minister for Trade and Investment, David Ridgway visits BBS’s facility - It was our great honour to host The Hon. David Ridgway, Minister of Trade and Investment, at BBS’s cultivation and… […]
Australian government unveils proposal for over-the-counter CBD - Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol to make… […]
BBS Pharmaceuticals welcomes newly appointed Head of Sales & Marketing - Michael Kromwyk has been appointed Head of Sales and Marketing at BBS Pharmaceuticals with responsibility for brand and marketing programs,… […]
BBS’s CEO John Dagas addresses Covid -19 and moving forward… - These are challenging times as the world responds to the coronavirus outbreak and sets a path to recovery. First off,… […]
Australia’s legal cannabis market predicted to bloom to $1.5 billion by 2025 - As various phases of legalisation come into effect in different parts of Australia, the country’s cannabis market is expected to… […]
Industry Breakthough as Australian Senate Committee pushes for legalisation and increased patient access to medicinal cannabis in Australia! - The Australian Senate Committee has revealed their recommendations from the inquiry 'Current barriers to patient access to medicinal cannabis in… […]
BBS Pharmaceuticals, a licensed cultivator and manufacturer of medicinal cannabis products would like to congratulate Minister David Littleproud and the Australian Parliament in passing the Export […]
It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour to welcome local Member of Hammond, […]
It has been a busy and incredibly productive start of the week here at BBS as we are entering the second half of the year. This […]
Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol to make it available over the counter in […]
Michael Kromwyk has been appointed Head of Sales and Marketing at BBS Pharmaceuticals with responsibility for brand and marketing programs, sales strategy, growing product sales, partnering […]
These are challenging times as the world responds to the coronavirus outbreak and sets a path to recovery. First off, our hearts go out to anyone […]
As various phases of legalisation come into effect in different parts of Australia, the country’s cannabis market is expected to break through the barrier of US$1.5 […]
The Australian Senate Committee has revealed their recommendations from the inquiry ‘Current barriers to patient access to medicinal cannabis in Australia’. In its 118-page long document, […]
In the coming months, the TGA will expand the number of quality audits of medicinal cannabis products imported or supplied under the Special Access Scheme (SAS) […]